|Day Low/High||67.59 / 69.48|
|52 Wk Low/High||30.79 / 70.82|
The firms all have drugs they want the feds to bend the rules to approve.
Materials, financials, cyclicals and health care names tilt the scale to the bullish side.
It's a very boring session with a narrow trading range as investors take break after four days of rally mode to digest Federal Reserve Chair Janet Yellen's latest comments. Some stocks of interest: Barclays moved Las Vegas Sands (LVS) to Overweight ...
Biotech IPOs that have relationships with established drug companies will do better than those going it alone.